Descriptive analysis assesses glycemic control and pharmacotherapy trends in adults with Type 2 diabetes, suggesting persistent disparities in treatment effectiveness.
Key Points
This study aims to assess long-term glycemic control and pharmacotherapy trends for Type 2 diabetes over a decade in a statewide sample.
Descriptive analysis of retrospective 10-year cohort data from the Indiana Health Information Exchange.
Population includes adults with Type 2 diabetes prescribed at least one diabetes drug.
Primary measures include glycemic success rates (A1c levels) and prescription rates of diabetes treatments.
Glycemic success was reported at 60%, with minimal year-to-year changes.
Glycemic success varied by demographics: 75%-89% for those aged 65 or above compared to 43%-62% for younger patients.
Racial disparities exist in newer drug prescriptions, with White patients receiving higher rates than non-White patients.